Study provides clearer picture of cancer risk

January 27, 2014 by Sarah Lyn Cobleigh Keblin, University of Vermont

(Medical Xpress)—A University of Vermont researcher has helped to develop a more accurate way of studying genetic changes to identify people at high risk for colon and other cancers. The findings are published in Nature Genetics.

Marc Greenblatt, M.D., an associate professor of medicine and oncologist at the University of Vermont (UVM) and Fletcher Allen Health Care, and faculty member at the Vermont Cancer Center's Familial Cancer Program, co-led a collaborative global effort to interpret genetic data related to hereditary colon cancer. The team's findings will both allow doctors to access publicly-available data to more effectively interpret risks and give patients a more accurate picture of familial risk for colon and other cancers.

The identification of a high-risk mutation in a cancer patient guides the clinical management of that patient and their family, including considerations for counselling, treatment options, surgery and other risk-reducing interventions. Lynch Syndrome is an inherited condition that greatly increases the risk for colon, uterine and other cancers. It is responsible for three to five percent of all colon cancers. For patients who are suspected of genetic variations that cause Lynch Syndrome, genetic test results have been difficult to interpret, therefore limiting the ability of these patients and their families to manage cancer risks.

Greenblatt and his international collaborators focused on in four genes that are responsible for Lynch Syndrome. Genetic testing to look for harmful mutations is frequently done. However, when genetic changes are found, about one quarter of them are difficult to interpret. Individuals presenting with these genetic variations have traditionally been told they have "variants of uncertain significance" – the results are inconclusive and cannot be used to help guide patient care or predict risk for family members.

The team of researchers, working through the International Society for Gastrointestinal Hereditary Cancers (InSiGHT), pooled the knowledge and collective data of more than 45 researchers and clinicians across the world, each with a specific type of expertise in the area of Lynch Syndrome. Together, they developed a new model of classifying , "in many cases turning indecipherable sequencing data into real knowledge that can have a clinical benefit," says Greenblatt.

"As a result of this work," he adds, "doctors can more conclusively say whether those patients have Lynch Syndrome, and focus prevention efforts on the family members who are at a high risk of getting . We may also ease the worry of some people who've had inconclusive results that turn out not to be dangerous. This team approach can also serve as a model for research efforts in the future on other genetic conditions."

Explore further: New genetic screening test for Lynch Syndrome

More information: "Application of a 5-tiered scheme for standardized classification of 2,360 unique mismatch repair gene variants in the InSiGHT locus-specific database." Bryony A Thompson, Amanda B Spurdle, John-Paul Plazzer, Marc S Greenblatt, Kiwamu Akagi, et al. Nature Genetics (2013) DOI: 10.1038/ng.2854. Received 19 September 2013 Accepted 26 November 2013 Published online 22 December 2013

Related Stories

New genetic screening test for Lynch Syndrome

December 24, 2013
People at high risk of cancer of the bowel and womb due to a genetic condition will receive a more accurate diagnosis as a result of a new model developed by a team of international scientists.

Study allows better prediction of the risk of hereditary cancer

January 15, 2014
An international study has developed a refined method to identify people at risk for certain inherited cancer as a result of Lynch syndrome.

Evidence mounts for endometrial cancer tumor testing to identify women with Lynch syndrome

December 11, 2013
A recent article by Norris Cotton Cancer Center researchers published in the January 2014 issue of the journal Clinical Chemistry reviews the scientific evidence that warrants screening all endometrial cancers for Lynch syndrome. ...

Researchers develop clinical screening program for no.1 genetic cause of colon cancer

February 14, 2013
(Medical Xpress)—Cleveland Clinic researchers have found that colorectal cancer outcomes could be improved with regular genetic screening for Lynch syndrome, the most common hereditary, adult-onset cause of colorectal cancer, ...

Study revises colorectal cancer risk down and other cancer risks up for women with Lynch Syndrome

February 26, 2013
Lynch Syndrome is a heritable genetic mutation that causes colorectal, endometrial and other cancers. A cooperative study that included the University of Colorado Cancer Center, published in this month's issue of the Journal ...

New Mayo Clinic test targets Lynch syndrome, a risk factor for colon cancer

May 18, 2011
Mayo Clinic has developed a screening procedure that could dramatically increase testing for Lynch syndrome, a hereditary genetic disorder that raises cancer risk, particularly for colorectal cancer. An estimated 3 percent ...

Recommended for you

Boosting cancer therapy with cross-dressed immune cells

January 22, 2018
Researchers at EPFL have created artificial molecules that can help the immune system to recognize and attack cancer tumors. The study is published in Nature Methods.

Workouts may boost life span after breast cancer

January 22, 2018
(HealthDay)—Longer survival after breast cancer may be as simple as staying fit, new research shows.

Cancer patients who tell their life story find more peace, less depression

January 22, 2018
Fifteen years ago, University of Wisconsin–Madison researcher Meg Wise began interviewing cancer patients nearing the end of life about how they were living with their diagnosis. She was surprised to find that many asked ...

Single blood test screens for eight cancer types

January 18, 2018
Johns Hopkins Kimmel Cancer Center researchers developed a single blood test that screens for eight common cancer types and helps identify the location of the cancer.

Researchers find a way to 'starve' cancer

January 18, 2018
Researchers at Vanderbilt University Medical Center (VUMC) have demonstrated for the first time that it is possible to starve a tumor and stop its growth with a newly discovered small compound that blocks uptake of the vital ...

How cancer metastasis happens: Researchers reveal a key mechanism

January 18, 2018
Cancer metastasis, the migration of cells from a primary tumor to form distant tumors in the body, can be triggered by a chronic leakage of DNA within tumor cells, according to a team led by Weill Cornell Medicine and Memorial ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.